Medication info

Empagliflozin 25 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Myung Moon Pharmaceutical Co., Ltd.
Appearance
Pale yellow, double convex, oval film-coated tablet
Packaging
10 tablets/box [10 tablets/PTPX1], 30 tablets/box [10 tablets/PTPX3], 30 tablets/bottle
Approval status
Active

MFDS item code 202102093 · Approved 2021.03.05

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this drug is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose on the same day. Special populations • Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this drug should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this drug well but have a persistent eGFR < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This drug should be discontinued if the eGFR decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this drug in patients with end-stage renal disease (ESRD) or who are on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of this drug is not recommended in adults aged 85 years and older because clinical experience is limited (see Precautions, 4. General Precautions).

Ingredients

Manufacturer
Myung Moon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Type 2 diabetes
  • difficulty with blood sugar control
  • cardiovascular disease
  • occurrence of cardiovascular events
View approved original text

This medication is used as an adjunct to diet and exercise to assist with blood sugar control in adult patients with type 2 diabetes mellitus. It can be administered as monotherapy, and when blood sugar control is difficult, it is treated in combination with metformin, pioglitazone, sulfonylureas, insulin, or DPP-4 inhibitors. Especially when used in patients with cardiovascular disease, it should be referenced with professional guidelines. This medication helps manage diabetes effectively through optimal blood sugar regulation.

How to take

Adult dose

The recommended dose of this drug is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose on the same day. Special populations • Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this drug should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this drug well but have a persistent eGFR < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This drug should be discontinued if the eGFR decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this drug in patients with end-stage renal disease (ESRD) or who are on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of this drug is not recommended in adults aged 85 years and older because clinical experience is limited (see Precautions, 4. General Precautions).

Precautions

This medication should not be administered to certain patients. For example, it should not be used in patients with an allergy to any of its ingredients, type 1 diabetes patients, patients with severe renal impairment, and patients with genetic metabolic disorders such as lactose intolerance. Patients with weak kidneys should use this medication cautiously. Particularly, if kidney function falls below a certain level, dose adjustment may be necessary, or the medication may need to be discontinued. Furthermore, it is not recommended for patients with end-stage renal disease or those undergoing dialysis as its effectiveness cannot be expected. In patients with heart failure, especially those with severe symptoms, the use of this medication is not recommended, and careful administration is necessary in mild cases as well. The risk of hypoglycemia may increase when this medication is used together with insulin or insulin secretagogues, hence, it is necessary to adjust the doses of these medications accordingly. During treatment, hypoglycemia, infections, especially genital infections and urinary tract infections may occur, so symptoms should be monitored closely. Additionally, since this medication can cause fluid loss, patients with symptoms of dehydration or low blood pressure should be monitored more closely. Patients taking this medication should have regular kidney function checks and are recommended to temporarily suspend its use in cases of acute illness or fasting due to surgery. Women who are pregnant or nursing are advised not to use this medication and should discontinue it immediately if pregnancy is confirmed. Safety in children and adolescents has not been established, so it is not used in those under 18 years of age. Although no specific toxic reactions have been reported with overdose, appropriate treatment should be sought based on the clinical status. This medication should be kept out of reach of children and should not be transferred to other containers. This medication may slightly affect the ability to drive or operate machinery, so caution is necessary, especially if there is a risk of hypoglycemia. Finally, it is important to closely monitor for unusual reactions or effects through regular consultations and examinations with healthcare professionals during the treatment.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vaginitis
  • balanitis
  • other genital infections
  • increased urination
  • dysuria
  • interstitial nephritis
  • pruritus
  • rash
Show 216 more
  • urticaria
  • angioedema
  • decreased fluid volume
  • thirst
  • increased serum lipids
  • elevated serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urinary tract infection
  • urosepsis
  • pyelonephritis
  • perineal gangrene
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral calculi
  • acute kidney injury
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • low back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • dialated retinal detachment
  • limb injuries
  • road traffic accidents
  • splenic injury
  • sternal fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign tumor of the ampulla of Vater
  • benign ovarian tumors
  • bladder cancer
  • stomach cancer
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • upper abdominal pain
  • cavities
  • gastric ulcer
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • rectal bleeding
  • chronic gastritis
  • ischemic colitis
  • enteritis
  • bloating
  • gastric polyps
  • gingival swelling
  • passage of blood in stool
  • hemorrhoids
  • pancreatic cysts
  • rectal pain
  • toothache
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • tinea capitis
  • dental abscess
  • nasopharyngitis
  • postural dizziness
  • sensory loss
  • perceptual abnormalities
  • amnesia
  • diabetic neuropathy
  • facial paralysis
  • memory abnormalities
  • neuralgia
  • Parkinson's disease
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • puncture site pain
  • weight gain
  • ECG abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • renal masses
  • urinary retention
  • urinary pain
  • urine abnormalities
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • hypoglycemia
  • reduced appetite
  • obesity
  • hyperphagia
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cysts
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • eye discomfort
  • conjunctival hyperemia
  • eyelid swelling
  • visual impairment
  • floaters
  • vitreous hemorrhage
  • nasal bleeding
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin lacerations
  • contusions
  • rib fractures
  • concussion
  • corneal abrasion
  • falls
  • hand fractures
  • iliotibial band syndrome
  • open globe injury
  • pelvic fractures
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • hepatitis
  • otalgia
  • postural vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • constipation
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to prolong its effectiveness.

Appearance and packaging

Appearance

Pale yellow, double convex, oval film-coated tablet

Package unit

10 tablets/box [10 tablets/PTPX1], 30 tablets/box [10 tablets/PTPX3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.